Status:
COMPLETED
Evaluation of a mHealth Intervention to Increase Adherence to Triage of Self-collected HPV+ Women (ATICA Project)
Lead Sponsor:
Centro de Estudio de Estado y Sociedad
Collaborating Sponsors:
Dana-Farber Cancer Institute
Deakin University
Conditions:
Patient Adherence
Eligibility:
FEMALE
30+ years
Phase:
NA
Brief Summary
Background: Cervical cancer is one of the leading causes of cancer death among women worldwide, with more than 85% of cases occurring in low- and middle-income countries. Human papillomavirus (HPV) sc...
Detailed Description
Cervical cancer is a disease of health and gender inequalities, and is primarily a cancer of poor, socially vulnerable women. Even though it is almost entirely preventable, in Latin America it is the ...
Eligibility Criteria
Inclusion
- In the Randomized Controlled Trial we will recruit a minimum of 4000 women, aged 30 and older living in the province of Jujuy, Argentina.
- Inclusion criteria are:
- Having performed self-collection of HPV-testing.
- Mentally competent to understand the consent form.
- Able to communicate with study staff.
- Being able to provide a mobile phone telephone number.
Exclusion
- Current pregnancy.
- Women with Mental disability.
Key Trial Info
Start Date :
December 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
5389 Patients enrolled
Trial Details
Trial ID
NCT03478397
Start Date
December 5 2018
End Date
August 31 2020
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple facilities
San Salvador de Jujuy, Jujuy Province, Argentina